The global Drugs for Osteoarthritis Pain market is projected to grow from US$ 9829.9 million in 2024 to US$ 13870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

Drugs for Osteoarthritis Pain Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Market Analysis and Insights: Global Drugs for Osteoarthritis Pain Market

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

Report Covers:

This report presents an overview of global market for Drugs for Osteoarthritis Pain market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Drugs for Osteoarthritis Pain, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs for Osteoarthritis Pain, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Osteoarthritis Pain revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Osteoarthritis Pain market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Osteoarthritis Pain revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Drugs for Osteoarthritis Pain Market Report

Report Metric	Details
Report Name	Drugs for Osteoarthritis Pain Market
Accounted market size in 2024	US$ 9829.9 million
Forecasted market size in 2030	US$ 13870 million
CAGR	5.9
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Oral Injection External
Segment by Application	Medical Care Personal Care
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drugs for Osteoarthritis Pain in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Osteoarthritis Pain revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Drugs for Osteoarthritis Pain Market growing?

Ans: The Drugs for Osteoarthritis Pain Market witnessing a CAGR of 5.9 during the forecast period 2024-2030.

What is the Drugs for Osteoarthritis Pain Market size in 2030?

Ans: The Drugs for Osteoarthritis Pain Market size in 2030 will be US$ 13870 million.

What is the Drugs for Osteoarthritis Pain Market share by region?

Ans: North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

What is the market share of major companies in Drugs for Osteoarthritis Pain Market?

Ans: Top 5 companies occupied about 66% market share.

Who are the main players in the Drugs for Osteoarthritis Pain Market report?

Ans: The main players in the Drugs for Osteoarthritis Pain Market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma

What are the Application segmentation covered in the Drugs for Osteoarthritis Pain Market report?

Ans: The Applications covered in the Drugs for Osteoarthritis Pain Market report are Medical Care, Personal Care

What are the Type segmentation covered in the Drugs for Osteoarthritis Pain Market report?

Ans: The Types covered in the Drugs for Osteoarthritis Pain Market report are Oral, Injection, External

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market by Application

1.3.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2019-2030)

2.2 Global Drugs for Osteoarthritis Pain Growth Trends by Region

2.2.1 Drugs for Osteoarthritis Pain Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs for Osteoarthritis Pain Historic Market Size by Region (2019-2024)

2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2025-2030)

2.3 Drugs for Osteoarthritis Pain Market Dynamics

2.3.1 Drugs for Osteoarthritis Pain Industry Trends

2.3.2 Drugs for Osteoarthritis Pain Market Drivers

2.3.3 Drugs for Osteoarthritis Pain Market Challenges

2.3.4 Drugs for Osteoarthritis Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Drugs for Osteoarthritis Pain by Players

3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Players (2019-2024)

3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2019-2024)

3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Drugs for Osteoarthritis Pain, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio

3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2023

3.5 Global Key Players of Drugs for Osteoarthritis Pain Head office and Area Served

3.6 Global Key Players of Drugs for Osteoarthritis Pain, Product and Application

3.7 Global Key Players of Drugs for Osteoarthritis Pain, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Osteoarthritis Pain Breakdown Data by Type

4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2019-2024)

4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2025-2030)

5 Drugs for Osteoarthritis Pain Breakdown Data by Application

5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2019-2024)

5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drugs for Osteoarthritis Pain Market Size (2019-2030)

6.2 North America Drugs for Osteoarthritis Pain Market Size by Type

6.2.1 North America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024)

6.2.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030)

6.2.3 North America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

6.3 North America Drugs for Osteoarthritis Pain Market Size by Application

6.3.1 North America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024)

6.3.2 North America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030)

6.3.3 North America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

6.4 North America Drugs for Osteoarthritis Pain Market Size by Country

6.4.1 North America Drugs for Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)

6.4.3 North America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Drugs for Osteoarthritis Pain Market Size (2019-2030)

7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type

7.2.1 Europe Drugs for Osteoarthritis Pain Market Size by Type (2019-2024)

7.2.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2025-2030)

7.2.3 Europe Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application

7.3.1 Europe Drugs for Osteoarthritis Pain Market Size by Application (2019-2024)

7.3.2 Europe Drugs for Osteoarthritis Pain Market Size by Application (2025-2030)

7.3.3 Europe Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country

7.4.1 Europe Drugs for Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)

7.4.3 Europe Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Drugs for Osteoarthritis Pain Market Size (2019-2030)

8.2 China Drugs for Osteoarthritis Pain Market Size by Type

8.2.1 China Drugs for Osteoarthritis Pain Market Size by Type (2019-2024)

8.2.2 China Drugs for Osteoarthritis Pain Market Size by Type (2025-2030)

8.2.3 China Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

8.3 China Drugs for Osteoarthritis Pain Market Size by Application

8.3.1 China Drugs for Osteoarthritis Pain Market Size by Application (2019-2024)

8.3.2 China Drugs for Osteoarthritis Pain Market Size by Application (2025-2030)

8.3.3 China Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Drugs for Osteoarthritis Pain Market Size (2019-2030)

9.2 Asia Drugs for Osteoarthritis Pain Market Size by Type

9.2.1 Asia Drugs for Osteoarthritis Pain Market Size by Type (2019-2024)

9.2.2 Asia Drugs for Osteoarthritis Pain Market Size by Type (2025-2030)

9.2.3 Asia Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

9.3 Asia Drugs for Osteoarthritis Pain Market Size by Application

9.3.1 Asia Drugs for Osteoarthritis Pain Market Size by Application (2019-2024)

9.3.2 Asia Drugs for Osteoarthritis Pain Market Size by Application (2025-2030)

9.3.3 Asia Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

9.4 Asia Drugs for Osteoarthritis Pain Market Size by Region

9.4.1 Asia Drugs for Osteoarthritis Pain Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Drugs for Osteoarthritis Pain Market Size by Region (2019-2024)

9.4.3 Asia Drugs for Osteoarthritis Pain Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type

10.2.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application

10.3.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country

10.4.1 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction

11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction

11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.2.5 Johnson & Johnson Recent Developments

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction

11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Developments

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction

11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.4.5 Bayer Recent Developments

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction

11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.5.5 Eli Lilly Recent Developments

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction

11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.6.5 Novartis Recent Developments

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction

11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.7.5 Sanofi Recent Developments

11.8 Horizon Pharma

11.8.1 Horizon Pharma Company Details

11.8.2 Horizon Pharma Business Overview

11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction

11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.8.5 Horizon Pharma Recent Developments

11.9 Abbott

11.9.1 Abbott Company Details

11.9.2 Abbott Business Overview

11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction

11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.9.5 Abbott Recent Developments

11.10 Mylan

11.10.1 Mylan Company Details

11.10.2 Mylan Business Overview

11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction

11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.10.5 Mylan Recent Developments

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Details

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction

11.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.11.5 Daiichi Sankyo Recent Developments

11.12 TEVA

11.12.1 TEVA Company Details

11.12.2 TEVA Business Overview

11.12.3 TEVA Drugs for Osteoarthritis Pain Introduction

11.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.12.5 TEVA Recent Developments

11.13 Almatica Pharma

11.13.1 Almatica Pharma Company Details

11.13.2 Almatica Pharma Business Overview

11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction

11.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.13.5 Almatica Pharma Recent Developments

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Details

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction

11.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.14.5 Astellas Pharma Recent Developments

11.15 Tide Pharmaceutical

11.15.1 Tide Pharmaceutical Company Details

11.15.2 Tide Pharmaceutical Business Overview

11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction

11.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.15.5 Tide Pharmaceutical Recent Developments

11.16 Iroko Pharmaceuticals

11.16.1 Iroko Pharmaceuticals Company Details

11.16.2 Iroko Pharmaceuticals Business Overview

11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction

11.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.16.5 Iroko Pharmaceuticals Recent Developments

11.17 Hengrui Pharmaceutical

11.17.1 Hengrui Pharmaceutical Company Details

11.17.2 Hengrui Pharmaceutical Business Overview

11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction

11.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.17.5 Hengrui Pharmaceutical Recent Developments

11.18 Abiogen Pharma

11.18.1 Abiogen Pharma Company Details

11.18.2 Abiogen Pharma Business Overview

11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction

11.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024)

11.18.5 Abiogen Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Iroko Pharmaceuticals

Hengrui Pharmaceutical

List of Tables

Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Key Players of External

Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2019-2024)

Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2025-2030)

Table 11. Drugs for Osteoarthritis Pain Market Trends

Table 12. Drugs for Osteoarthritis Pain Market Drivers

Table 13. Drugs for Osteoarthritis Pain Market Challenges

Table 14. Drugs for Osteoarthritis Pain Market Restraints

Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2019-2024)

Table 17. Global Top Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2023)

Table 18. Global Drugs for Osteoarthritis Pain Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served

Table 21. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application

Table 22. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2019-2024)

Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2025-2030)

Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2019-2024)

Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2025-2030)

Table 32. North America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Drugs for Osteoarthritis Pain Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Drugs for Osteoarthritis Pain Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)

Table 64. Pfizer Company Details

Table 65. Pfizer Business Overview

Table 66. Pfizer Drugs for Osteoarthritis Pain Product

Table 67. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 68. Pfizer Recent Developments

Table 69. Johnson & Johnson Company Details

Table 70. Johnson & Johnson Business Overview

Table 71. Johnson & Johnson Drugs for Osteoarthritis Pain Product

Table 72. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 73. Johnson & Johnson Recent Developments

Table 74. GlaxoSmithKline Company Details

Table 75. GlaxoSmithKline Business Overview

Table 76. GlaxoSmithKline Drugs for Osteoarthritis Pain Product

Table 77. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 78. GlaxoSmithKline Recent Developments

Table 79. Bayer Company Details

Table 80. Bayer Business Overview

Table 81. Bayer Drugs for Osteoarthritis Pain Product

Table 82. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 83. Bayer Recent Developments

Table 84. Eli Lilly Company Details

Table 85. Eli Lilly Business Overview

Table 86. Eli Lilly Drugs for Osteoarthritis Pain Product

Table 87. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 88. Eli Lilly Recent Developments

Table 89. Novartis Company Details

Table 90. Novartis Business Overview

Table 91. Novartis Drugs for Osteoarthritis Pain Product

Table 92. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 93. Novartis Recent Developments

Table 94. Sanofi Company Details

Table 95. Sanofi Business Overview

Table 96. Sanofi Drugs for Osteoarthritis Pain Product

Table 97. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 98. Sanofi Recent Developments

Table 99. Horizon Pharma Company Details

Table 100. Horizon Pharma Business Overview

Table 101. Horizon Pharma Drugs for Osteoarthritis Pain Product

Table 102. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 103. Horizon Pharma Recent Developments

Table 104. Abbott Company Details

Table 105. Abbott Business Overview

Table 106. Abbott Drugs for Osteoarthritis Pain Product

Table 107. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 108. Abbott Recent Developments

Table 109. Mylan Company Details

Table 110. Mylan Business Overview

Table 111. Mylan Drugs for Osteoarthritis Pain Product

Table 112. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 113. Mylan Recent Developments

Table 114. Daiichi Sankyo Company Details

Table 115. Daiichi Sankyo Business Overview

Table 116. Daiichi Sankyo Drugs for Osteoarthritis Pain Product

Table 117. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 118. Daiichi Sankyo Recent Developments

Table 119. TEVA Company Details

Table 120. TEVA Business Overview

Table 121. TEVA Drugs for Osteoarthritis Pain Product

Table 122. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 123. TEVA Recent Developments

Table 124. Almatica Pharma Company Details

Table 125. Almatica Pharma Business Overview

Table 126. Almatica Pharma Drugs for Osteoarthritis Pain Product

Table 127. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 128. Almatica Pharma Recent Developments

Table 129. Astellas Pharma Company Details

Table 130. Astellas Pharma Business Overview

Table 131. Astellas Pharma Drugs for Osteoarthritis Pain Product

Table 132. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 133. Astellas Pharma Recent Developments

Table 134. Tide Pharmaceutical Company Details

Table 135. Tide Pharmaceutical Business Overview

Table 136. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product

Table 137. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 138. Tide Pharmaceutical Recent Developments

Table 139. Iroko Pharmaceuticals Company Details

Table 140. Iroko Pharmaceuticals Business Overview

Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product

Table 142. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 143. Iroko Pharmaceuticals Recent Developments

Table 144. Hengrui Pharmaceutical Company Details

Table 145. Hengrui Pharmaceutical Business Overview

Table 146. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product

Table 147. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 148. Hengrui Pharmaceutical Recent Developments

Table 149. Abiogen Pharma Company Details

Table 150. Abiogen Pharma Business Overview

Table 151. Abiogen Pharma Drugs for Osteoarthritis Pain Product

Table 152. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)

Table 153. Abiogen Pharma Recent Developments

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Drugs for Osteoarthritis Pain Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Injection Features

Figure 5. External Features

Figure 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Drugs for Osteoarthritis Pain Market Share by Application: 2023 VS 2030

Figure 8. Medical Care Case Studies

Figure 9. Personal Care Case Studies

Figure 10. Drugs for Osteoarthritis Pain Report Years Considered

Figure 11. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Region: 2023 VS 2030

Figure 14. Global Drugs for Osteoarthritis Pain Market Share by Players in 2023

Figure 15. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2023

Figure 17. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

Figure 20. North America Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)

Figure 21. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

Figure 25. Europe Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

Figure 26. Europe Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)

Figure 27. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

Figure 35. China Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

Figure 36. Asia Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

Figure 38. Asia Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

Figure 39. Asia Drugs for Osteoarthritis Pain Market Share by Region (2019-2030)

Figure 40. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)

Figure 50. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 57. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 58. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 59. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 60. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 61. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 62. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 63. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 64. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 65. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 66. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 67. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 68. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 69. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 70. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 71. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 72. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 73. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions